These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9013124)

  • 1. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis.
    Winn LM; Wells PG
    Free Radic Biol Med; 1997; 22(4):607-21. PubMed ID: 9013124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative damage in chemical teratogenesis.
    Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
    Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
    Winn LM; Wells PG
    Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
    Miranda AF; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice.
    Kasapinovic S; McCallum GP; Wiley MJ; Wells PG
    Free Radic Biol Med; 2004 Dec; 37(11):1703-11. PubMed ID: 15528029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.
    Liu L; Wells PG
    Free Radic Biol Med; 1995 Nov; 19(5):639-48. PubMed ID: 8529923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic prostaglandin H synthase-2 (PHS-2) expression and benzo[a]pyrene teratogenicity in PHS-2 knockout mice.
    Parman T; Wells PG
    FASEB J; 2002 Jul; 16(9):1001-9. PubMed ID: 12087061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin embryotoxicity: role of enzymatic bioactivation in a murine embryo culture model.
    Shanks MJ; Wiley MJ; Kubow S; Wells PG
    Teratology; 1989 Oct; 40(4):311-20. PubMed ID: 2814893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat, and rabbit.
    Ozolins TR; Wiley MJ; Wells PG
    Biochem Pharmacol; 1995 Nov; 50(11):1831-40. PubMed ID: 8615862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis.
    Parman T; Chen G; Wells PG
    J Biol Chem; 1998 Sep; 273(39):25079-88. PubMed ID: 9737965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for Ras-dependent signal transduction in phenytoin teratogenicity.
    Winn LM; Wells PG
    Toxicol Appl Pharmacol; 2002 Nov; 184(3):144-52. PubMed ID: 12460742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxidase-dependent bioactivation and oxidation of DNA and protein in benzo[a]pyrene-initiated micronucleus formation.
    Kim PM; DeBoni U; Wells PG
    Free Radic Biol Med; 1997; 23(4):579-96. PubMed ID: 9215804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
    Lee CJ; Gonçalves LL; Wells PG
    FASEB J; 2011 Jul; 25(7):2468-83. PubMed ID: 21502285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
    Kim PM; Winn LM; Parman T; Wells PG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for glutathione, independent of oxidative stress, in the developmental toxicity of methanol.
    Siu MT; Shapiro AM; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):508-15. PubMed ID: 24095963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity.
    Winn LM; Wells PG
    Free Radic Biol Med; 1999 Feb; 26(3-4):266-74. PubMed ID: 9895216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
    Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
    Parman T; Wiley MJ; Wells PG
    Nat Med; 1999 May; 5(5):582-5. PubMed ID: 10229238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.